QIAGEN powered by

Pharmaceutical Development Bioinformatics Services

Whether validating predictive biomarkers, designing a new companion diagnostic (CDx), or honing your study accrual and go-to-market strategies, we have the pharmaceutical bioinformatics service offerings to set you on the path to success

Unlock the power of drug development data

Having data that are consistent, reliable, and well understood is one of the biggest challenges facing pharmaceutical research and development.

To bring the power of precision medicine to more patients, pharmaceutical companies must overcome the barriers of finding, capturing, converting and organizing actionable data for improved decision making throughout the drug development process. 

From research to regulatory submission, our pharmaceutical bioinformatics services help you connect data to insight for optimal biomarker selection, efficient clinical trial accrual, and faster drug development. 

Cancer drug development takes years. What if there's a faster way?​

Oncology drug development can take up to 15 years, cost millions of dollars, and often relies on sparse data that doesn’t provide a full picture of a target patient population. But what if there’s a faster, safer, and more cost-effective way?

In the June 2020 issue of the Journal of Precision Medicine, Dr. Sheryl Elkin, CSO of QIAGEN Digital Insights, discusses the use of real-world genomic data to overcome the inefficiencies of drug development.

Optimize your drug development strategy 

Across the drug development lifecycle, our pharmaceutical bioinformatics services provide customized support for your program—from the earliest stages of strategy and planning through FDA approval to commercialization. 

Pharmaceutical  Bioinformatics Services:

  • Translational data analysis
  • Real-World Insights (RWI)
  • Customized projects
  • Consulting 
Customer Success Story

How Debiopharm uses real-world genomic data to support drug development

Dr. Anna Pokorska-Bocci of Debiopharm International shares her experience working with QIAGEN’s Real-World Insights team and how the customized analyses and offerings provided have enabled Debiopharm to accelerate drug development.

Leverage QIAGEN Real-World Insights

The majority of cancer patients today are diagnosed and treated outside the context of clinical research—that is, in the real world. 

QIAGEN’s Real-World Insights (RWI) is a professional and personalized pharmaceutical bioinformatics service dedicated to finding the fastest, most cost-effective route to move therapies from research to market.

Customize your cancer drug development project

Create and deliver bespoke drug development projects with a range of flexible options and services tailored to your unique requirements. 

Our pharmaceutical bioinformatics services team works with you to develop the informatics tools and evidence resources you need to get consistent, reliable, and actionable results through all phases of your study.

Strategize with expert guidance 

Looking for an experienced partner with a shared passion for innovation? QIAGEN Pharmaceutical Development Bioinformatics Services deliver valuable insights to support a successful clinical drug development plan with minimal time, effort and cost. 

We work as an extension of your team, providing strategic consulting services to maximize the impact of your research, study and go-to-market plan. 

Get started today

Request a consultation with one of our pharmaceutical development bioinformatics specialists to discuss your specific research requirements.

Biomarker and Cancer Indication Selection

Choose the best biomarkers and cancer indications for your molecularly targeted therapies​

Molecular Profiling and Response Analyses

Expand beyond the one biomarker, one drug paradigm with expert molecular profiling and drug-response analyses

Trial Accrual and Drug Market Plans

More easily find the right patients and quickly move to recruitment and regulatory acceptance​

Pharmaceutical Bioinformatics Services | QIAGEN